BellRock Brands Inc
BellRock Brands Inc. develops, markets, and sells cannabis products in the United States, Canada, and internationally. It offers cannabis infused adult-use topicals, confections, edibles, beverages, and concentrates, as well as transdermal patches, tinctures, capsules, lotions, creams, other topicals, vapes, and cosmetic serums. The company also provides branded hemp-infused products for humans a… Read more
BellRock Brands Inc (DXBRF) - Net Assets
Latest net assets as of June 2020: $-6.81 Million USD
Based on the latest financial reports, BellRock Brands Inc (DXBRF) has net assets worth $-6.81 Million USD as of June 2020.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.94 Million) and total liabilities ($15.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-6.81 Million |
| % of Total Assets | -76.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 41.43 |
BellRock Brands Inc - Net Assets Trend (2016–2019)
This chart illustrates how BellRock Brands Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BellRock Brands Inc (2016–2019)
The table below shows the annual net assets of BellRock Brands Inc from 2016 to 2019.
| Year | Net Assets | Change |
|---|---|---|
| 2019-12-31 | $-4.13 Million | -125.93% |
| 2018-12-31 | $15.94 Million | +820.24% |
| 2017-12-31 | $-2.21 Million | -208.79% |
| 2016-12-31 | $2.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BellRock Brands Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4476318400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2019)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $41.56 Million | % |
| Other Components | $7.31 Million | % |
| Total Equity | $-2.58 Million | 100.00% |
BellRock Brands Inc Competitors by Market Cap
The table below lists competitors of BellRock Brands Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EVEN3F
SA:EVEN3F
|
$10.98K |
|
SPARK NEW (NZT.SG)
STU:NZT
|
$10.99K |
|
DOWNING RNW.+INFR.TR.-01
F:8V0
|
$10.99K |
|
Caelum Co. Ltd.
KO:258610
|
$10.99K |
|
SHANDONG MOLONG -H-
MU:PXI
|
$10.98K |
|
Flight International Co., Ltd.
TWO:6798
|
$10.98K |
|
General Aviation Import Export JSC
VN:ARM
|
$10.97K |
|
From Bio Co. Ltd.
KO:377220
|
$10.96K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BellRock Brands Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2018 to 2019, total equity changed from 17,672,756 to -2,576,159, a change of -20,248,915 (-114.6%).
- Net loss of 20,140,089 reduced equity.
- Other comprehensive income decreased equity by 250,000.
- Other factors increased equity by 141,174.
Equity Change Factors (2018 to 2019)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-20.14 Million | -781.79% |
| Other Comprehensive Income | $-250.00K | -9.7% |
| Other Changes | $141.17K | +5.48% |
| Total Change | $- | -114.58% |
Book Value vs Market Value Analysis
This analysis compares BellRock Brands Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.02 | $0.00 | x |
| 2017-12-31 | $-0.01 | $0.00 | x |
| 2018-12-31 | $0.30 | $0.00 | x |
| 2019-12-31 | $-0.02 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BellRock Brands Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -181.49%
- • Asset Turnover: 1.14x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-74.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -182.03% | -169.33% | 0.40x | 2.71x | $-4.25 Million |
| 2017 | 0.00% | -120.98% | 0.53x | 0.00x | $-3.87 Million |
| 2018 | -114.83% | -350.40% | 0.23x | 1.41x | $-22.06 Million |
| 2019 | 0.00% | -181.49% | 1.14x | 0.00x | $-19.88 Million |
Industry Comparison
This section compares BellRock Brands Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BellRock Brands Inc (DXBRF) | $-6.81 Million | -182.03% | N/A | $10.98K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |